These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4674127)

  • 1. Amphetamine controls and OHIP.
    Rapp MS
    Can Med Assoc J; 1972 Oct; 107(8):721-2. PubMed ID: 4674127
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphetamine controls.
    Constantin LY
    Can Med Assoc J; 1973 Apr; 108(7):823-4. PubMed ID: 4707226
    [No Abstract]   [Full Text] [Related]  

  • 3. Amphetamine controls.
    Akins K
    Can Med Assoc J; 1972 Jul; 107(2):113. PubMed ID: 5064963
    [No Abstract]   [Full Text] [Related]  

  • 4. Attitudes of Ontario psychiatrists towards health insurance.
    Lippman DH; Lowy FH; Rickhi B
    Can Med Assoc J; 1981 Jul; 125(2):167-70. PubMed ID: 7272866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of amphetamine preparations.
    Br Med J; 1968 Nov; 4(5630):572-3. PubMed ID: 5722324
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of amphetamines in the Republic of Ireland.
    Timoney RF
    J Ir Med Assoc; 1972 Feb; 65(3):57-61. PubMed ID: 5060442
    [No Abstract]   [Full Text] [Related]  

  • 7. How the federal government's amphetamine controls will work.
    Geekie DA
    Can Med Assoc J; 1973 Jan; 108(1):83-4. PubMed ID: 4682643
    [No Abstract]   [Full Text] [Related]  

  • 8. Amphetamines and their derivatives.
    Haynes WS
    Med J Aust; 1970 Mar; 1(11):566. PubMed ID: 5443517
    [No Abstract]   [Full Text] [Related]  

  • 9. Diversion of narcotic and stimulant drugs.
    Whalen RP; Silverman R
    N Y State J Med; 1975 Apr; 75(5):735-7. PubMed ID: 1054792
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of d-amphetamine and related central nervous system stimulants in children.
    Pediatrics; 1973 Feb; 51(2):302-5. PubMed ID: 4695865
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of wekamines on humans].
    Sloot HA
    Pharm Weekbl; 1969 Aug; 104(35):1075-8. PubMed ID: 5806269
    [No Abstract]   [Full Text] [Related]  

  • 12. Voluntary restriction of amphetamines.
    Br Med J; 1968 Nov; 4(5630):532-3. PubMed ID: 5722312
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug treatment courts are popular but do they work and are they ethical and appropriate for Canada?
    Christie T; Anderson JF
    Health Law Can; 2003 May; 23(4):70-9. PubMed ID: 12845932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug scene in Alaska.
    Hilburn MB
    Alaska Med; 1972 Jan; 14(1):26-9. PubMed ID: 5063400
    [No Abstract]   [Full Text] [Related]  

  • 15. Methadone controls.
    Bishop J
    Can Med Assoc J; 1972 Oct; 107(8):722. PubMed ID: 4674128
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological aspects of drug abuse.
    Fastier FN
    N Z Med J; 1970 Dec; 72(463):400-2. PubMed ID: 5278260
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug abuse--American dilemma.
    Head M
    J Kans Med Soc; 1973 Jan; 74(1):9-11. PubMed ID: 4682783
    [No Abstract]   [Full Text] [Related]  

  • 18. An outbreak of intravenous amphetamine abuse in heroin addicts.
    Greene MH; DuPont RL
    Proc Natl Conf Methadone Treat; 1973; 1():776-85. PubMed ID: 4808232
    [No Abstract]   [Full Text] [Related]  

  • 19. Amphetamine controls.
    Geekie DA
    Can Med Assoc J; 1972 May; 106(10):1124. PubMed ID: 4402342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychohygienic aspects of drug dependence and alcohol abuse].
    Langen D
    Arztl Forsch; 1969 Oct; 23(10):349-56. PubMed ID: 5396094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.